Eli Lilly has introduced Mounjaro (tirzepatide), a once-weekly injectable drug approved by the Central Drugs Standard Control Organisation (CDSCO), for the treatment of type 2 diabetes and weight loss in India. The drug is expected to be available in pharmacies across the country in the coming weeks with a valid prescription. Dual Receptor Mechanism Mounjaro …